Search Results - "Popova, Stanislava Dimitrova"
-
1
Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer's model of adult zebrafish brain
Published in PLoS biology (01-01-2020)“…It was recently suggested that supplying the brain with new neurons could counteract Alzheimer's disease (AD). This provocative idea requires further testing…”
Get full text
Journal Article -
2
A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu
Published in Life (Basel, Switzerland) (08-02-2022)“…The role of IFN-α-induced chemokines CCL2, CXCL10 and CCL19 in different forms of SLE has not been studied in Bulgaria, with worldwide sources attributing…”
Get full text
Journal Article -
3
Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Published in BMC cancer (17-07-2015)“…About 3885 women are diagnosed with breast cancer and 1285 die from the disease each year in Bulgaria. However no genetic testing to identify the mutations in…”
Get full text
Journal Article -
4
Serum and Synovial Levels of Cathepsin G and Cathepsin K in Patients with Psoriatic Arthritis and Their Correlation with Disease Activity Indices
Published in Diagnostics (Basel) (01-10-2023)“…This retrospective case-control study examined the relationship between the serum and synovial levels of cathepsin G (CatG) and cathepsin K (CatK) in patients…”
Get full text
Journal Article -
5
Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application
Published in Life (Basel, Switzerland) (01-11-2023)“…Febuxostat, initially developed as a xanthine oxidase inhibitor to address hyperuricemia in gout patients, has evolved into a versatile therapeutic agent with…”
Get full text
Journal Article -
6
Erratum to: Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients
Published in BMC cancer (16-03-2017)“…In this version of this article that was originally published [1] there was an error with the citation in the line: “…Functional studies suggested that c.536A…”
Get full text
Journal Article -
7
Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review
Published in Life (Basel, Switzerland) (22-11-2023)“…Janus kinase (JAK) inhibitors have heralded a paradigm shift in the management of immune-mediated diseases. While their efficacy is well-established, the…”
Get full text
Journal Article